http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104171921-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L7-109 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L7-109 |
filingDate | 2014-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-104171921-B |
titleOfInvention | Special low albumen noodles of diabetic nephropathy patients undergoing and preparation method thereof |
abstract | The present invention relates to noodles technical field, particularly to a kind of special low albumen noodles of diabetic nephropathy patients undergoing: 0 30 parts of flour, α modified starch 0 30 parts, wheaten starch 40 100 parts, golden needle fungus or wheat bran 18 parts, sodium carboxymethyl cellulose 0.1 0.3 parts, 0.1 0.3 parts of carbonate, phosphate 0.01 0.08 parts, 58 parts of medicine food dual purpose plant powder.Product protein content is less than 4g/100g, calculates according to the daily ingestion of 500g of diabetic nephropathy patient, and non-prime albumen intake is less than 20g, meets its nutritional requirement;By adding appropriate golden needle fungus, Testa Tritici etc., significantly reduce the glycaemic index of product, Diabetic Nephropathy Patients carbohydrate metabolism is had certain regulation effect;Add medicine food dual purpose plant powder, utilize the antioxidant activity of polyphenol isoreactivity material therein, reduce diabetic nephropathy patient vivo oxidation stress level, there is certain adjuvant treatment effect. |
priorityDate | 2014-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.